Three molecular changes are the most crucial for diagnosing GBM, namely the concurrent gain of whole chromosome 7 and loss of whole chromosome 10 (+7/−10), TERT promoter mutation, and EGFR amplification. This evidence concerns the gene EGFR and glioblastoma.